Literature DB >> 1149180

Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat.

B D Myers, W M Deen, B M Brenner.   

Abstract

In 26 Wistar rats with surface glomeruli, the determinants of glomerular ultrafiltration and peritubular capillary uptake of proximal reabsorbate were studied before and during intravenous infusions of norepinephrine or angiotensin II. Regardless of whether renal perfusion pressure (AP) was permitted to increase, both hormones produced elevations in single nephron filtration fraction due to declines in glomerular plasma flow with little change in nephron glomerular filtration rate. The resulting large increases in the efferent arteriolar oncotic pressure, piE, were accompanied by equivalent increases in the mean glomerular transcapillary hydraulic pressure difference, deltaP. Equality of piE and deltaP, denoting filtration pressure equilibrium, obtained before and during infusion of either hormone. Por both hormones, when elevations in AP were allowed, marked and roughly proportional increases in the resistance to blood flow through single afferent and efferent arterioles occurred, whereas when increases in AP were prevented by partial aortic constriction increases in resistance were confined primarily to the efferent arteriole. Tespite the marked increases in piE, absolute rates of proximal tubule fluid reabsorption, on the average, were unchanged by these hormones due to the opposing effects of marked decreases in efferent arteriolar plasma flow rate and, to a lesser extent, increases in peritubular capillary hydraulic pressure.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149180     DOI: 10.1161/01.res.37.1.101

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  63 in total

Review 1.  Remission of renal disease: recounting the challenge, acquiring the goal.

Authors:  Barry M Brenner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Noradrenaline and the kidney: foe, friend, or both?

Authors:  Martin Matejovic; Karl Träger; Daniel De Backer
Journal:  Intensive Care Med       Date:  2005-08-09       Impact factor: 17.440

3.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors:  E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

Review 4.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

5.  Renal function impairment induced by change in posture in patients with cirrhosis and ascites.

Authors:  M Bernardi; C Santini; F Trevisani; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

6.  Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion.

Authors:  V Kon; A Yared; I Ichikawa
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

7.  Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.

Authors:  R W Steiner; B J Tucker; R C Blantz
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole.

Authors:  S Ito; S Arima; Y L Ren; L A Juncos; O A Carretero
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

9.  Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla.

Authors:  J R Ingelfinger; R E Pratt; K Ellison; V J Dzau
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 10.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.